Drug DrugBank | All Description Patterns💬 Info on mouse-over
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY On map, Yellow: Drug target genes |
Disease ID |
| 1 | Behavioral: assessment of impact of ms on cognition | - | - | - | - | 013 [1] 13 💬 |
| 2 | Behavioral: low-impact exercise control | - | - | - | - | 006 [1] 6 💬 |
| 3 | Behavioral: tip / impact plus care coordination | - | - | - | - | 046 [3] 46, 96, 97 💬 |
| 4 | Impact | - | - | - | - | 006 [8] 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
| 5 | Impact-nutridrink | - | - | - | - | 299 [1] 299 💬 |
| 6 | Nutridrink-impact | - | - | - | - | 299 [1] 299 💬 |
| 7 | Other: acute response to high-impact exercise | - | - | - | - | 096 [1] 96 💬 |
| 8 | Other: high-impact exercise intervention | - | - | - | - | 096 [1] 96 💬 |
| 9 | Other: impact of biotherapy on postoperative morbidity in ulcerative colitis | - | - | - | - | 097 [1] 97 💬 |
| 10 | Other: impact peptide 1.5 | - | - | - | - | 299 [1] 299 💬 |
| 11 | Other: non impact aerobics | - | - | - | - | 013 [1] 13 💬 |